Press Releases

Current Articles | Categories | Search | Syndication

01 September 2014  Rebecca Bellars
Less than 40% of people in the UK understand the pathologist’s vital role in diagnosing cancer
By Rebecca Bellars @ 14:13 :: 12 Views

n the eve of the European Congress of Pathology in London, new research shows the pathologist’s critical role in tackling cancer is not widely understood.

Chalfont St Giles, 29 August 2014 – As the European Congress of Pathology begins this weekend in London, new research from GE Healthcare shows that many people do not understand the importance of the pathologist in the diagnosis and treatment of breast cancer1, the most common cancer in Europe, with more than 464,000 new cases diagnosed in 2012.

Read More

19 August 2014  Joanne Hunter
Advanced Cell Diagnostics and Leica Biosystems Begin Co-marketing Fully Automated RNA in situ Hybridization Assay
By Joanne Hunter @ 08:43 :: 118 Views

MELBOURNE, AUSTRALIA & HAYWARD, CALIFORNIA, August 13, 2014: Leica Biosystems and Advanced Cell Diagnostics, Inc. (ACD) have announced the co-marketing of ACD's RNAscope® LS ISH assays with Leica Biosystems' BOND RX research staining platform*. This agreement provides researchers with an integrated and fully automated ISH solution. The market-leading RNAscope LS reagent kits and ISH probes are available from ACD while the BOND RX instrument and associated reagents are supplied by Leica Biosystems.

Read More

12 August 2014  Joanne Hunter
Liver disease: developments in the understanding and assessment of liver fibrosis
By Joanne Hunter @ 15:27 :: 130 Views

According to recent statistics1 deaths from liver disease have risen by 40% between 2001 and 2012 and the disease is the only major disease group in which annual deaths are on the rise. With this in mind it becomes increasingly important to measure liver fibrosis, the scarring process that represents the liver’s response to injury or disease. Liver fibrosis is the final common pathway of all chronic liver disease (CLD), and most of these liver diseases are asymptomatic and the patient is unaware of the symptoms until it is often too late. 

Read More

29 July 2014  Joanne Hunter
Siemens offers educational resources to share best practice and enhance knowledge
By Joanne Hunter @ 14:35 :: 226 Views

In support of the increasing need for training and reference materials in diagnostic laboratories, Siemens Healthcare Diagnostics has announced the extended availability of a number of educational resources for laboratory staff. These  include a range of wall posters and case studies to assist haematology departments with staff development, along with a series of webinars offering personalised education, training and management solutions.

Read More

22 July 2014  Joanne Hunter
New data using EKF PointMan™ technology suggest the possibility of a simple blood test for cancers
By Joanne Hunter @ 11:17 :: 316 Views

Cardiff, UK – 21st July 2014 – EKF Diagnostics, the global diagnostics company, announces that the latest results from its collaboration with the Institute of Life Sciences at the University of Swansea, UK, have continued to confirm the effectiveness of its PointMan™ DNA enrichment technology for isolating and characterizing low-level DNA mutations in blood. This is significant since with such sensitivity, it paves the way for the possibility of using a simple blood test to screen and diagnose different cancers, as well as monitor the efficacy of anti-cancer therapies.

Read More

16 July 2014  Joanne Hunter
New Iam CMV provides rapid molecular confirmation of congenital CMV infection
By Joanne Hunter @ 10:40 :: 310 Views

DiaSorin strengthens its infectious disease diagnostic portfolio for mothers and babies with the launch of the Iam CMV assay for the molecular detection of cytomegalovirus.

DiaSorin has further expanded its range of infectious disease assays for use on the DiaSorin Liaison® Iam analyser with the launch of a new molecular assay for the rapid and reliable detection of cytomegalovirus (CMV). Intra-uterine transmission of CMV to the foetus during pregnancy is the leading viral cause of congenital infection, affecting around 1% of live births1. The DiaSorin Iam CMV assay detects clinically relevant subtypes of CMV in human amniotic fluid, plasma, urine and cerebrospinal fluid (CSF)2, making it a valuable tool for the diagnosis of maternal and foetal CMV infection in early pregnancy and for monitoring CMV infection in affected babies.

Read More

15 July 2014  Joanne Hunter
Battling Antibiotic Resistance New QuickFISH Rapid Pathogen Species Diagnostic Test could help
By Joanne Hunter @ 09:03 :: 295 Views

It was recently announced that the Longitude Prize 2014 will focus on the ability to “create a cost-effective, accurate, rapid and easy-to-use test for bacterial infections” to help combat the scourge of antibiotic resistant microbial infection, putting this critical and growing problem under the spotlight again.
The AdvanDx QuickFISH test, exclusively available in the UK from Alpha Laboratories Ltd. could provide a solution. 

Read More

08 July 2014  Joanne Hunter
New Iam HSV provides rapid molecular confirmation of HSV infection in pregnant women and neonates
By Joanne Hunter @ 14:12 :: 289 Views

DiaSorin has further strengthened its range of infectious disease diagnostic assays for maternal and neonatal health with the launch of Iam HSV for use with the DiaSorin Liaison® Iam analyser.  The launch of this new molecular assay provides rapid and reliable differential detection of herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) in human cerebrospinal fluid (CSF), vesicle swabs, plasma and whole blood.  Together with Iam VZV for the detection of clinically relevant subtypes of Varicella Zoster Virus (VZV), these assays allow the rapid and reliable detection of alphaherpesvirus infections in pregnant women and neonates.

Read More

08 July 2014  Rebecca Bellars
Blood test for Alzheimer’s moves considerably closer
By Rebecca Bellars @ 09:13 :: 301 Views

Proteome Sciences is pleased to announce publication of a study it has co-authored with King’s College London in which a set of 10 proteins in the blood have been identified which can predict the onset of Alzheimer’s disease. The study which analysed over 1,000 individuals is the largest of its kind to date and marks a significant step towards developing a blood test for the disease. 

Read More

08 July 2014  Joanne Hunter
Derby HospitalNHS FoundationTrust Selects Hologic’sThinPrep Technology for Cervical Screening Programme
By Joanne Hunter @ 08:45 :: 557 Views

Five‐year contract makes Royal Derby Hospital largest ThinPrep processing lab in the UK  

BEDFORD, Mass., July 7, 2014 ‐ Hologic, Inc. today announced it entered into a five‐year contract for its ThinPrep Pap tests and processing equipment with Derby Hospitals NHS Foundation Trust. With this agreement, Royal Derby Hospital will be the largest ThinPrep processing laboratory in the UK with an estimated 150,000 samples processed annually.  

Read More

Previous Page | Next Page